journal article·2021-12Open access

Snapshot imprinting: rapid identification of cancer cell surface proteins and epitopes using molecularly imprinted polymers

Stanislav S. Piletsky, Elena Piletska, Marta Poblocka, Salvador Macip, Donald J.L. Jones, Marta Braga, Thong H. Cao, Rajinder Singh, Alan C. Spivey, Eric O. Aboagye, Sergey A. Piletsky

Nano Today· Volume 41

Abstract

Proteomic mapping of cell surfaces is an invaluable tool for drug development and clinical diagnostics. This work describes a new ‘snapshot imprinting’ method designed to obtain proteomic maps of cell surfaces, with the aim of identifying cell surface markers and epitopes for diagnostic and therapeutic applications. The analysis of two cancer cell lines, HN5 and MDA-MB-468, is described herein as a proof of concept, along with the selective targeting of three identified epitopes of epidermal growth factor receptor using molecularly imprinted polymer nanoparticles. 438 proteins were identified using this technique, with 283 considered to be transmembrane or extracellular proteins. The major advantage of the molecular imprinting approach developed here is the ability to analyse cell surface proteins without tedious fractionation, affinity separation or labelling. We believe that this system of protein analysis may provide a basic molecular diagnostics toolbox for precise, personalised treatment of cancer and other diseases.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Blood groups and transfusion · Advanced Proteomics Techniques and Applications · Caveolin-1 and cellular processes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (42)

Show source-provided references
1. Subcellbarcode: proteome-wide mapping of protein localization and relocalization10.1016/j.molcel.2018.11.035 ↗
2. Drug-target network10.1038/nbt1338 ↗
3. Large-scale identification of membrane proteins based on analysis of trypsin-protected transmembrane segments10.1016/j.jprot.2016.03.016 ↗
4. Proteomic analysis of integral plasma membrane proteins10.1021/ac0354037 ↗
5. Spatially resolved proteomic mapping in living cells with the engineered peroxidase APEX210.1038/nprot.2016.018 ↗
6. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants10.1016/0005-2736(76)90160-7 ↗
7. Universal sample preparation method for proteome analysis10.1038/nmeth.1322 ↗
8. Reliable FASP-based procedures for optimal quantitative proteomic and phosphoproteomic analysis on samples from acute myeloid leukemia patients10.1186/s12575-016-0043-0 ↗
9. Combining phenotypic and proteomic approaches to identify membrane targets in a ‘triple negative’ breast cancer cell type10.1186/1476-4598-12-11 ↗
10. S. Piletsky, E. Piletska, F. Canfarotta, D. Jones, Methods and kits for determining binding sites. GB1704823.2., 2018. 〈https://patents.google.com/patent/WO2018178629A1/en〉 (accessed February 5, 2020).
11. Plastic antibodies: developments and applications10.1016/S0167-7799(98)01222-0 ↗
12. Solid-phase synthesis of molecularly imprinted nanoparticles10.1038/nprot.2016.030 ↗
13. Molecularly imprinted polymers for cell recognition10.1016/j.tibtech.2019.10.002 ↗
14. EGFR inhibition as a therapy for head and neck squamous cell carcinoma10.1517/13543784.17.10.1517 ↗
15. Triple negative breast cancer: unmet medical needs10.1007/s10549-010-1293-1 ↗
16. The proteomic landscape of triple-negative breast cancer10.1016/j.celrep.2015.03.050 ↗
17. Targeting the EGFR signaling pathway in cancer therapy10.1517/14728222.2011.648617 ↗
18. The 14-3-3 cancer connection10.1038/nrc1230 ↗
19. The biology and role of CD44 in cancer progression: therapeutic implications10.1186/s13045-018-0605-5 ↗
20. Repressing CD147 is a novel therapeutic strategy for malignant melanoma10.18632/oncotarget.15709 ↗
21. Surfomics: shaving live organisms for a fast proteomic identification of surface proteins10.1016/j.jprot.2013.03.035 ↗
22. Non-classical protein secretion in bacteria10.1186/1471-2180-5-58 ↗
23. Non-conventional protein secretionin yeast10.1016/j.tim.2005.11.009 ↗
24. Secretion of the housekeeping protein glyceraldehyde-3-phosphate dehydrogenase by the LEE-encoded type III secretion system in enteropathogenic Escherichia coli10.1016/j.biocel.2012.03.002 ↗
25. Nucleosomes bind to cell surface proteoglycans10.1074/jbc.274.31.21707 ↗
26. Direct translocation of histone molecules across cell membranes10.1242/jcs.00757 ↗
27. Endothelial and cancer cells interact with mesenchymal stem cells via both microparticles and secreted factors10.1111/jcmm.12391 ↗
28. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells10.1038/ncb1725 ↗
29. Retracted article: exosomes from glioma cells induce atumor-like phenotype in mesenchymal stem cells by activating glycolysis10.1186/s13287-019-1149-5 ↗
30. Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid10.1021/pr300606e ↗
31. Interaction of microtubules and actin during the post-fusion phase of exocytosis10.1038/s41598-019-47741-0 ↗
32. Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb®, GW572016) in an expanded panel of human normal and tumour cell lines10.1111/j.1365-2184.2007.00455.x ↗
33. Nucleoside-tailored molecularly imprinted polymeric nanoparticles (MIP NPs)10.1021/ma501530c ↗
34. Preparation of abiotic polymer nanoparticles for sequestration and neutralization of a target peptide toxin10.1038/nprot.2015.032 ↗
35. Recognition, neutralization, and clearance of target peptides in the bloodstream of living mice by molecularly imprinted polymer nanoparticles: a plastic antibody10.1021/ja102148f ↗
36. HEMA-induced cytotoxicity: oxidative stress, genotoxicity and apoptosis10.1111/iej.12232 ↗
37. Effects of acrylate/acrylamide polymers on the adhesion, growth and differentiation of Muse cells
38. Proteomics of plasma membrane microdomains10.1586/14789450.2.5.793 ↗
39. Tube-gel digestion: a novel proteomic approach for high throughput analysis of membrane proteins10.1074/mcp.M500138-MCP200 ↗
40. Plasma membrane proteomics of human embryonic stem cells and human embryonal carcinoma cells10.1021/pr800056j ↗
41. Estimation of membrane proteins in the human proteome10.3233/ISB-00251 ↗
42. Identification of biomarkers in human head and neck tumor cell lines that predict for in vitro sensitivity to gefitinib10.1111/j.1752-8062.2009.00099.x ↗